About China Biologic Products
China Biologic Products, Inc. (China Biologic) is a biopharmaceutical company. The Company is principally engaged in the research, development, manufacturing and sales of human plasma-based biopharmaceutical products in China. It operates in the manufacture and sales of human plasma products segment. It has a product portfolio with over 20 various dosage forms of plasma products and other biopharmaceutical products across over nine categories. Its principal products are human albumin and immunoglobulin for intravenous injection (IVIG). China Biologic operates its business through approximately two subsidiaries, namely, Shandong Taibang Biological Products Co. Ltd. and Guizhou Taibang Biological Products Co., Ltd. The Company also holds an interest in Xi'an Huitian Blood Products Co., Ltd., a plasma products company. Its products also include Human rabies immunoglobulin, Human tetanus immunoglobulin, Placenta polypeptide, Factor VIII and Human prothrombin complex concentrate.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Biotechnology
- Sub-Industry: N/A
- Exchange: NASDAQ
- Symbol: CBPO
- Previous Close: $110.15
- 50 Day Moving Average: $111.57
- 200 Day Moving Average: $116.19
- 52-Week Range: $100.53 - $137.38
- Trailing P/E Ratio: 29.17
- Foreward P/E Ratio: 17.05
- P/E Growth: 1.11
- Market Cap: $2.96B
- Outstanding Shares: 27,137,000
- Beta: 1.78
- Net Margins: 30.63%
- Return on Equity: 19.61%
- Return on Assets: 17.04%
Companies Related to China Biologic Products:
- Current Ratio: 6.01%
- Quick Ratio: 3.98%
What is China Biologic Products' stock symbol?
China Biologic Products trades on the NASDAQ under the ticker symbol "CBPO."
Where is China Biologic Products' stock going? Where will China Biologic Products' stock price be in 2017?
2 brokerages have issued twelve-month price objectives for China Biologic Products' stock. Their predictions range from $129.00 to $155.00. On average, they expect China Biologic Products' stock price to reach $142.00 in the next twelve months.
When will China Biologic Products announce their earnings?
China Biologic Products is scheduled to release their next quarterly earnings announcement on Tuesday, May, 2nd 2017.
Who owns China Biologic Products stock?
China Biologic Products' stock is owned by many different of retail and institutional investors. Top institutional shareholders include FMR LLC (5.43%), Baillie Gifford & Co (Scottish partnership) (5.21%), Baillie Gifford & Co. (5.21%), FIL Ltd (3.14%), Davidson Kempner Capital Management LP (1.00%) and Investec Asset Management LTD (0.84%). Company insiders that own China Biologic Products stock include David Gao, Ming Yang, Ming Yin, Wenfang Liu, Wp X Biologics Llc, Zhijing Cbpo Liu and Zhijun Tong.
Who sold China Biologic Products stock? Who is selling China Biologic Products stock?
China Biologic Products' stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Indus Capital Partners LLC, Baillie Gifford & Co., Credit Agricole S A, Calamos Advisors LLC, Matthews International Capital Management LLC, Fiera Capital Corp and Oberweis Asset Management Inc.. Company insiders that have sold China Biologic Products stock in the last year include Ming Yang, Ming Yin, Wenfang Liu, Wp X Biologics Llc and Zhijing Cbpo Liu.
Who bought China Biologic Products stock? Who is buying China Biologic Products stock?
China Biologic Products' stock was acquired by a variety of institutional investors in the last quarter, including FMR LLC, FIL Ltd, Russell Investments Group Ltd., Artisan Partners Limited Partnership, Allianz Asset Management AG, Investec Asset Management LTD, Capstone Investment Advisors LLC and Trexquant Investment LP.
How do I buy China Biologic Products stock?
Shares of China Biologic Products can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of China Biologic Products stock cost?
One share of China Biologic Products stock can currently be purchased for approximately $109.10.